Precision BioSciences, Inc.
DTIL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $45 | $62 | $77 | $86 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $2 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $7 | $8 | $5 | $7 |
| Total Curr. Assets | $52 | $70 | $82 | $95 |
| Property Plant & Equip (Net) | $8 | $9 | $9 | $10 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1 | $0 | $0 | $1 |
| Long-Term Investments | $32 | $1 | $3 | $3 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $29 | $29 | $27 |
| Total NC Assets | $42 | $39 | $42 | $41 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $94 | $109 | $124 | $136 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $1 | $1 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $6 | $6 | $6 | $3 |
| Other Curr. Liab. | $6 | $5 | $4 | $9 |
| Total Curr. Liab. | $15 | $14 | $12 | $15 |
| LT Debt | $28 | $28 | $28 | $29 |
| Deferred Rev, NC | $30 | $30 | $31 | $33 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $4 | $3 | $4 | $3 |
| Total NC Liab. | $62 | $61 | $63 | $65 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $7 | $7 | $8 |
| Total Liabilities | $77 | $75 | $75 | $80 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$548 | -$527 | -$503 | -$482 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $565 | $561 | $552 | $539 |
| Total Equity | $17 | $34 | $49 | $56 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $94 | $109 | $124 | $136 |
| Net Debt | -$16 | -$33 | -$47 | -$56 |